Yoko Fujita‐Yamaguchi

Author

Also Known As

Fujita-Yamaguchi Yoko, Y FUJITAYAMAGUCHI, Y Fujita-Yamaguchi, Y. Fujita-Yamaguchi, Y. Fujitayamaguchi, Y. Fujita-Yamaguchi, YOKO FUJITA-YAMAGUCHI, Yoko FUJITA-YAMAGUCHI, Yoko FUJITA‐YAMAGUCHI, Yoko Fujita-Yamaguchi

121

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

City of Hope Beckman Research Institute Tokai University City Of Hope National Medical Center Hope Research Institute

About

Yoko Fujita‐Yamaguchi is an author at City of Hope specializing in medicine, biochemistry, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	47	2.5K
2	Natural Sciences	11	12	590
3	Health Sciences	5	5	258
4	Engineering	4	4	116
5	Public Health	1	1	40

Yoko Fujita‐Yamaguchi

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. Shinji Tamura, Thomas A. Brown, Judith H. Whipple, Journal of Biological Chemistry	1984	347
Tyrosine-specific protein kinase activity is associated with the purified insulin receptor. Masato Kasuga, Yoko Fujita‐Yamaguchi, Diana Blithe, Proceedings of the National Academy of Sciences GlycobiologyInsulin ReceptorInsulin SignalingGastrointestinal Peptide HormoneMolecular Pharmacology	1983	321
Purification of insulin receptor with full binding activity. Yoko Fujita‐Yamaguchi, Sang‐Bong Choi, Yujiro Sakamoto, Journal of Biological Chemistry	1983	273
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Giuseppe Pandini, Riccardo Vigneri, Angela Costantino, PubMed Breast OncologyInsulin ReceptorBreast CancersCancer BiologyInsulin Signaling	1999	257
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Vincenzo Papa, Biancamaria Gliozzo, Clark Gm, PubMed Breast OncologyPathologyHuman Breast CancerIgf-i ReceptorInsulin Signaling	1993	252
Characterization of the insulin receptor kinase purified from human placental membranes. Masato Kasuga, Yoko Fujita‐Yamaguchi, Diana Blithe, Journal of Biological Chemistry ImmunologyInsulin ReceptorInsulin SignalingReceptor Tyrosine KinaseCell Signaling	1983	195
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Deepali Sachdev, Shu Lian Li, Julie S. Hartell, PubMed Breast OncologyImmunologyIgf ActionImmunotherapyCancer Biology	2003	188
The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. Katsu-ichi Sakano, Tomoko Enjoh, Fumio Numata, Journal of Biological Chemistry	1991	146
Insulin‐Like Growth Factor (IGF) System Components in Human Prostatic Cancer Cell‐Lines: LNCaP, DU145, and PC‐3 Cells Go Kimura, Junko Kasuya, Stefano Giannini, International Journal of Urology	1996	118
Down-regulation of Insulin Receptor by Antibodies against the Type I Insulin-Like Growth Factor Receptor: Implications for Anti–Insulin-Like Growth Factor Therapy in Breast Cancer Deepali Sachdev, Rajeeva Singh, Yoko Fujita‐Yamaguchi, Cancer Research	2006	115

Page 1